Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cytosine methylation analysis of adult mixed phenotype acute leukemia (MPAL)

ABSTRACT: Cytosine methylation analysis of adult mixed phenotype acute leukemia (MPAL)

PROVIDER: PRJNA451487 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA sequencing analysis of adult mixed phenotype acute leukemia (MPAL)

Project description:RNA sequencing analysis was performed from bone marrow samples of 24 adult mixed phenotype acute leukemia (MPAL) patients

2018-04-25 | GSE113601 | GEO

Analysis of mixed phenotype acute leukemia

Project description:Analysis of mixed phenotype acute leukemia

| PRJNA839172 | ENA

Cytosine methylation analysis of adult mixed phenotype acute leukemia (MPAL)

Project description:Cytosine methylation analysis of genomic DNA from 31 MPAL patients bone marrow samples was performed using Illumina’s Infinium MethylationEPIC Kit (EPIC) that covers approximately 850,000 CpG probes (Illumina, San Diego, CA).

2018-04-24 | GSE113545 | GEO

RNA sequencing analysis of adult mixed phenotype acute leukemia (MPAL)

Project description:RNA sequencing analysis of adult mixed phenotype acute leukemia (MPAL)

| PRJNA453199 | ENA

Single-cell, multi-omic analysis identifies regulatory programs in mixed phenotype acute leukemia

Project description:We present a single-cell framework that integrates highly multiplexed protein quantification, transcriptome profiling, and chromatin accessibility analysis. Using this approach, we establish a normal epigenetic baseline for healthy blood development, which we then use to deconvolve aberrant molecular features within blood from mixed-phenotype acute leukemia (MPAL) patients.

2019-10-25 | GSE139369 | GEO

Acute myeloid leukemia with mixed phenotype is characterized by stemness features with limited lineage plasticity

Project description:Mixed phenotype (MP) in acute leukemias poses unique classification and management dilemmas and can be seen in entities other than de novo mixed phenotype acute leukemia (MPAL). Although WHO classification empirically recommends excluding AML with myelodysplasia related changes (AML-MRC) and therapy related AML (t-AML) with mixed phenotype (referred to as “AML-MP”) from MPAL, there is lack of studies investigating the clinical, genetic, and biologic features of AML-MP. We report the first cohort of AML-MP integrating their clinical, immunophenotypic, genomic and transcriptomic features with comparison to MPAL and AML without MP. Patients with AML-MP share similar clinical and genetic features to its AML counterpart but differs from MPAL. AML-MP harbors more frequent RUNX1 mutations than AML without MP and MPAL. RUNX1 mutations or complex karyotypes did not impact the survival of MPAL patients. Unsupervised hierarchal clustering based on immunophenotype identified biologically distinct clusters with phenotype/genotype correlation and outcome differences. Furthermore, transcriptomic analysis showed an enrichment for stemness signature in AML-MP and AML without MP as compared to MPAL. Lastly, MPAL but not AML-MP often switched to lymphoid only immunophenotype after treatment. Expression of transcription factors critical for lymphoid differentiation were upregulated only in MPAL, but not in AML-MP. Our study for the first time demonstrates that AML-MP clinically and biologically resembles its AML counterpart without MP and differs from MPAL, supporting the recommendation to exclude these patients from the diagnosis of MPAL. Future studies are needed to elucidate the molecular mechanism of mixed phenotype in AML.

2024-08-28 | GSE275859 | GEO

ETV6-NCOA2 expression profile in T/M mixed-phenotype acute leukemia [ETV6_NCOA2_Mouse_in_vitro]

Project description:ETV6-NCOA2 expression profile in T/M mixed-phenotype acute leukemia [ETV6_NCOA2_Mouse_in_vitro]

| PRJNA679211 | ENA

14q32 recombinations deregulating BCL11B mark a distinct Mixed Phenotype Leukemia

Project description:14q32 recombinations deregulating BCL11B mark a distinct Mixed Phenotype Leukemia

| PRJNA681239 | ENA

Single-cell, multi-omic analysis identifies regulatory programs in mixed phenotype acute leukemia

Project description:Single-cell, multi-omic analysis identifies regulatory programs in mixed phenotype acute leukemia

| PRJNA579391 | ENA

ChIP sequencing of ETV6-NCOA2 H3K27Ac profile in T/M mixed-phenotype acute leukemia

Project description:ChIP sequencing of ETV6-NCOA2 H3K27Ac profile in T/M mixed-phenotype acute leukemia